Cite
HARVARD Citation
Tang, Z. et al. (2017). Advantage of Sorafenib Combined with Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma. Tumori. 103 (3), pp. 286-291. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tang, Z. et al. (2017). Advantage of Sorafenib Combined with Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma. Tumori. 103 (3), pp. 286-291. [Online].